French life science cluster the Medicen Paris Region has been recruited to play a key role in a newly-launched European regenerative medicine project.
The four-year, €3.3m BONE project will see impacts developed using electrospinning – a procedure that uses electric charges to pull fibres from liquid.
These impacts, produced by Maastricht University in the Netherlands, have been tipped to become an alternative to repeat surgeries, prolonged medication use and donor tissue.
Medicen, a cluster of 300 life science organisations, will be responsible for activities relating to the dissemination and long-term impact of the project, as well as overall monitoring and matchmaking.
Béatrice Falise-Mirat, CEO of Medicen Paris Region, said: “Regenerative medicine is one of our five strategic activities; it is important to position each one at the European level.
“It’s a wonderful example of inter-cluster collaboration internationally and the added value that clusters can provide for European ecosystems.”
The initiative will unite Maastricht, Leuven and Lille universities along with the Fraunhofer Institute for Laser Technology ILT in Germany and technology firms based in the UK, Denmark and Ireland.
“We are thrilled that we are able to position the cluster and, more specifically the Ile-de-France region, in such an international context,” Falise-Mirat added.
The project – funded by the Interreg North-West Europe Program – has a total budget of €3.3m ($3.8m), and it is expected that the cluster will benefit from 15 new jobs, two new products and €162,000 ($185,000) in funding spread over the course of the project.